A large body of research, based on both clinical trials and meta-analysis, has evaluated the effectiveness of various diabetes medications, including insulin therapies, metformin, sulfonylureas, GLP-1 receptor agonists, SGLT2 inhibitors, DPP-4 inhibitors, and thiazolidinediones (9). This evidence concerns the gene INS and diabetes mellitus.